Price T Rowe Associates Inc Centessa Pharmaceuticals PLC Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Price T Rowe Associates Inc holds 4,679,021 shares of CNTA stock, worth $81.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,679,021

Previous 3,530,373 32.54%

Holding current value

$81.9 Million

Previous $31.9 Million 134.69%

% of portfolio

0.01%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$8.58 - $16.99 $9.86 Million - $19.5 Million	1,148,648 Added 32.54%	4,679,021 $74.8 Million
Q2 2024 Aug 14, 2024	BUY	$8.04 - $11.87 $4.6 Million - $6.79 Million	572,294 Added 19.35%	3,530,373 $31.9 Million
Q1 2024 May 15, 2024	BUY	$6.73 - $12.2 $2.82 Million - $5.11 Million	418,615 Added 16.48%	2,958,079 $33.4 Million
Q4 2023 Feb 14, 2024	SELL	$5.52 - $8.03 $53,378 - $77,650	-9,670 Reduced 0.38%	2,539,464 $20.2 Million
Q3 2023 Nov 14, 2023	BUY	$6.01 - $8.24 $1.12 Million - $1.53 Million	185,923 Added 7.87%	2,549,134 $16.5 Million
Q2 2023 Aug 14, 2023	BUY	$3.68 - $6.9 $183,183 - $343,468	49,778 Added 2.15%	2,363,211 $14.6 Million
Q1 2023 May 15, 2023	SELL	$3.03 - $4.0 $223,414 - $294,936	-73,734 Reduced 3.09%	2,313,433 $8.91 Million
Q4 2022 Feb 14, 2023	SELL	$3.05 - $4.19 $179,388 - $246,439	-58,816 Reduced 2.4%	2,387,167 $7.4 Million
Q3 2022 Nov 14, 2022	SELL	$3.8 - $5.91 $57,558 - $89,518	-15,147 Reduced 0.62%	2,445,983 $9.83 Million
Q2 2022 Aug 15, 2022	SELL	$3.18 - $9.85 $214,500 - $664,412	-67,453 Reduced 2.67%	2,461,130 $12 Million
Q1 2022 May 16, 2022	BUY	$7.45 - $11.59 $3.37 Million - $5.24 Million	451,813 Added 21.76%	2,528,583 $22.7 Million
Q4 2021 Feb 14, 2022	BUY	$10.99 - $17.54 $647,278 - $1.03 Million	58,897 Added 2.92%	2,076,770 $23.4 Million
Q3 2021 Nov 15, 2021	BUY	$16.7 - $23.11 $113,560 - $157,148	6,800 Added 0.34%	2,017,873 $33.1 Million
Q2 2021 Aug 16, 2021	BUY	$21.71 - $25.66 $43.7 Million - $51.6 Million	2,011,073 New	2,011,073 $43.9 Million

Others Institutions Holding CNTA

# of Institutions

107

Shares Held

118M

Call Options Held

5.9K

Put Options Held

53K

View Full List

About Centessa Pharmaceuticals plc

Ticker CNTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,339,296
Market Cap $1.65B
Description
Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...

More about CNTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Centessa Pharmaceuticals PLC Transaction History